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Abstract
Background: Achieving the Sustainable Development Goal of a 90% reduction in neglected tropical diseases
(NTDs) by 2030 requires innovative control strategies.
This proof-of-concept study examined the effectiveness of integrating control programs for two NTDs: mass drug
administration (MDA) for soil-transmitted helminths in humans and mass dog rabies vaccination (MDRV).
Methods: The study was carried out in 24 Tanzanian villages. The primary goal was to demonstrate the feasibility
of integrating community-wide MDA for STH and MDRV for rabies. The objectives were to investigate the
popularity, participation and cost and time savings of integrated delivery, and to investigate the reach of the MDA
with respect to primary school-aged children and other community members. To implement, we randomly
allocated villages for delivery of MDA and MDRV (Arm A), MDA only (Arm B) or MDRV only (Arm C).
Results: Community support for the integrated delivery was strong (e.g. 85% of focus group discussions concluded
that it would result in people getting “two for one” health treatments). A high proportion of households
participated in the integrated Arm A events (81.7% MDA, 80.4% MDRV), and these proportions were similar to those
in Arms B and C. These findings suggest that coverage might not be reduced when interventions are integrated.
Moreover, in addition to time savings, integrated delivery resulted in a 33% lower cost per deworming dose and a
16% lower cost per rabies vaccination.
The median percentage of enrolled primary school children treated by this study was 76%. However, because 37%
of the primary school aged children that received deworming treatment were not enrolled in school, we
hypothesize that the employed strategy could reach more school-aged children than would be reached through a
solely school-based delivery strategy.
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Conclusions: Integrated delivery platforms for health interventions can be feasible, popular, cost and time saving.
The insights gained could be applicable in areas of sub-Saharan Africa that are remote or underserved by health
services. These results indicate the utility of integrated One Health delivery platforms and suggest an important role
in the global campaign to reduce the burden of NTDs, especially in hard-to-reach communities.
Trial registration: clinicaltrials.gov NCT03667079, retrospectively registered 11th September 2018.
Keywords: Neglected tropical disease, Soil transmitted helminths, Rabies, One health, Integrated mass drug
delivery, Tanzania
Introduction
Almost a quarter of the world’s human population suffer
the effects of 20 recognised neglected tropical diseases
(NTDs) [1–5]. Despite the considerable investment that
followed the Sustainable Development Goal of a 90% re-
duction in NTDs by 2030, the control of NTDs, which
are poverty-promoting and occur primarily in rural areas
of low-income countries, remains a profound health
challenge [5, 6]. Novel, cost-effective, complementary
and far-reaching control strategies are required to ad-
dress this challenge.
The One Health concept recognises that the health of
humans, animals and the environment are linked and that
a multidisciplinary approach is required to address com-
plex health problems [7, 8]. Given the role that all three
factors play in the epidemiology of many NTDs, control
efforts guided by the One Health approach has merit.
This study focuses on two NTDs endemic in East Af-
rica: soil transmitted helminths (STH) and canine rabies.
STH, a group of parasitic worms (including roundworms
(Ascaris lumbricoides), whipworms (Trichuris trichuria)
and hookworms (Necator americanus, Ancylostoma duo-
denale)), infect more than 1.5 billion people in tropical
and sub-tropical countries [9]. Where sanitation is poor,
eggs present in human faeces contaminate the soil, ex-
posing people, especially children, to infection through
egg ingestion via dirty hands, contaminated water or
food, and through the skin, especially while walking
barefoot. Whilst STH can be treated, untreated cases are
associated with pregnancy complications, anaemia, mal-
nutrition and impaired early childhood physical and cog-
nitive development and susceptibility to other diseases
[10–14]. Fincham et al [13] and Le Hesran et al [14]
Sparse data limits accurate prevalence estimates of STH
across East Africa, however N. americanus is the most
widely distributed species with other species having
more restricted distributions [15].
In response to the World Health Organization’s (WHO)
goal of treating more than 75% of school aged and pre-
school aged children in endemic areas (an estimated 651.5
million) by 2020 [16], school-based mass drug administra-
tion (MDA) programs have been implemented as a cost-
effective method of addressing the population group that
bears the greatest burden of morbidity. In the United Re-
public of Tanzania, the 2017 national coverage of school-
aged children receiving preventive chemotherapy for STH
through the national primary school based deworming
program (NSDP) was 90% [17]. In remote regions
however, school-based programs can miss a significant
proportion of children due to low attendance [18]. Add-
itionally, some STH infections, such as hook worm, can
be prevalent in adult populations. Therefore, if local elim-
ination of STH is the goal then treatment of all age groups
will be required [19].
Canine mediated human rabies is an NTD [5] respon-
sible for 59,000 deaths and $8.6 billion in economic
losses annually with rural Africa having the highest inci-
dence (3.6 cases per 100,000) [20, 21]. Figures such as
these have led the WHO, the Food & Agricultural
Organization (FAO) and the World Organization for
Animal Health (OIE) to recognize rabies as a global
health priority and have committed to its elimination by
2030 (‘Zero by 30’) [22]. For this commitment to suc-
ceed, domestic dog vaccine delivery must be expanded
from local to regional scales [23]. One barrier is the dif-
ficulty of consistently achieving the required coverage of
70% of the dog population across the hard-to-reach
landscapes that characterize much of sub-Saharan Africa
and Asia [24–26]. Where vaccination strategies rely on
delivery through annual campaigns, low turnout in a few
communities can jeopardise the success of the wider
programme. Furthermore, team-led mass dog rabies vac-
cination (MDRV) campaigns are expensive, with costs
up to $6.36 per dog vaccinated [26, 27].
The integration of preventative NTD programs with
similar strategic approaches offers opportunities for fi-
nancial and personnel cost savings, as well as improved
program effectiveness through the wider adoption of in-
tegration strategies [28]. There are examples of inte-
grated human health delivery strategies, for example the
Schistosomiasis Control Initiative has included drugs
targeting STH to its praziquantel regimen and the Afri-
can Program for Onchocerciasis Control has provided
an entry point for other community-directed health in-
terventions [29–31]. However only one example could
be found where preventative programs targeting human
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health have been integrated with programs targeting ani-
mal health [32]. In the Schelling et al. study (referred
hereafter as the Chad Study) it was reported that com-
bining vaccination for nomadic pastoralists and their
livestock in to a single delivery program was a popular
approach that resulted in reduced operational costs.
The overarching goal of this proof-of-concept study was
to demonstrate the feasibility of the concept of integrating
community-wide MDA for STH and MDRV for rabies.
The first objective was to determine whether coupling
MDA with MDRV was socially acceptable. The second
objective was to investigate how integration impacted a)
household participation, b) dog vaccination coverage, c)
administration and delivery costs and d) travel time to
attend clinics. The third objective was to quantify the
impact of the study’s MDA strategy on reaching primary
school-aged children (whether or not enrolled in school)
and other community members.
Our approach was unconventional because it coupled
the responsibilities of the Ministries of human and ani-
mal health into one program with the shared aim of pre-
venting multiple NTDs, and it allowed families to bring
themselves and their dogs for treatment at one location.
This integrated perspective is in line with the ‘One
Health’ approach to disease control.
Methods
The study was carried out in the Ngorongoro District,
Tanzania inhabited by semi-nomadic Maasai people. The
remote area was chosen because MDRV and MDA are
carried out in the region as separate programs. The MDA
program delivers twice yearly deworming treatment to
every primary school and is coordinated by the District
Medical Office (DMO). The MDRV program vaccinates
dogs annually and is coordinated by the District Veterin-
ary Office. The MDA and MDRV carried out in this study
were one cycle of the established MDA and MDRV in the
target villages, respectively. The study took place between
February and October 2016, however activities were sus-
pended during the rainy season (April – May) to avoid in-
clement weather from affecting participation.
The study focused on 24 villages selected because they
are located within the eight wards immediately sur-
rounding the district’s administrative centre. Each of the
24 villages were randomly assigned using a computer
randomisation function [33] to one of three arms: i)
Arm A (n = 8) received both MDA and MDRV; ii) Arm
B (n = 8) received MDA only; iii) Arm C (n = 8) received
MDRV only. All villages were equally likely to be
assigned to each arm. The distribution of villages be-
tween the arms and a summary of activities are shown
in Fig. 1. As per the established MDA and MDRV pro-
grams, a nurse from the DMO and two village-based
community health workers carried out the MDA whilst
a rabies field team (a veterinarian, two field staff and a
ward-based person) delivered the MRDV. STH and / or
rabies awareness information was provided to respon-
dents in the form of verbal disease avoidance advice.
Villages in this region cover a large area, and all are di-
vided into sub-village units. Each intervention (‘event’) was
delivered at the level of the sub-village using a ‘central-
point’ strategy [34], which required villagers to travel from
their homes to the central-point event to receive treatment.
Village leaders estimated that hosting each sub-village event
for 1 day would provide sufficient time for villagers to at-
tend. Consequently, each event was scheduled to last for 1
day, and the number of days the team(s) spent in each vil-
lage equalled the number of sub-villages. Because the num-
ber of sub-villages ranged between two and six per village,
the duration to complete each village was always less than
one working week. Consequently, each new village event
began on a Monday.
Arm A events comprised an MDA and a MDRV clinic
hosted concurrently, while Arm B and Arm C events
comprised only one clinic (MDA or MDRV, respect-
ively). For Arm A villages, the MDA and MDRV delivery
teams travelled together in one vehicle and set up the
clinics close to each other. For Arm B and C villages, the
MDA and MDRV teams travelled separately.
In order to quantify the impact of the study’s MDA
strategy on reaching primary school-aged children
(whether or not enrolled in school) (third objective) the
events were all hosted during the school term. In sub-
villages with a primary school, the clinics were posi-
tioned outside the school grounds, whilst in sub-villages
that did not have a primary school the clinics were lo-
cated in a central location.
To inform each community of the event, a village-wide
meeting was convened 1 week before. Key information
provided at the meeting included STH and / or rabies
awareness information and the importance of controlling
these conditions through MDA and MDRV, the date of
each clinic, that treatment would be given free of charge,
and that people and dogs of all ages were invited to at-
tend. On the Sunday prior to a village event, a motorbike
rider with a loudspeaker drove around each village an-
nouncing the event details. Additionally, the DMO in-
formed the head teacher of each primary school of the
date that the event would be convened outside of the
school grounds. At 0830 h the clinic(s) would be set up
in the predetermined location and the treatment teams
would wait for villagers to arrive. People coming to the
MDA clinic were registered and research data collected
(see below). Following this, and as stipulated by the
standard operating procedure of the program coordi-
nated by the DMO, children between 12 and 59months
were given an oral dose of mebendazole (500 mg) and
vitamin A (100,000 IU), people over 59 months were
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given an oral dose of albendazole (400mg), and pregnant
women were not treated [35]. Following arrival and regis-
tration at the MDRV clinics, dogs were vaccinated (Nobi-
vac Rabies®, MSD Animal Health, Boxmeer, Netherlands),
a collar placed around the neck and water-soluble purple
coloured paint was applied to both flanks. People attend-
ing the combined clinic (Arm A) who had also brought
dogs were instructed to visit the MDRV clinic after receiv-
ing deworming treatment. The events ended at 1630 h. Fi-
nancial administrative costs were collected and used to
estimate the cost per treatments under each arm. Eco-
nomic costs of household participation were collected in
the form of travel time and monetized using standard as-
sumptions about time costs.
Objective 1: community perceptions and knowledge
To gauge opinions about integrated intervention strat-
egies individual interviews (n = 59) with village leaders
and focus group discussions (FGD, n = 30, attempting
one men’s and one women’s per village) with a range of
participants (range: 8–14, total = 341, mean = 11 / FGD)
were carried out.
For the individual interviews, between two and three
key informants were selected per village using a combin-
ation of purposeful and opportunistic sampling of village
leaders (teachers, officials, traditional leaders, etc.). We
first approached village government leaders, the Village
Chairperson (elected position) or Village Executive Officer
(district government appointed position), to determine a
participant list of leaders who occupied a pre-determined
range of positions of respect (including traditional leaders,
teachers, or other members of the village government).
Participants from this list were then selected based upon
availability. We, therefore, interviewed both those in gov-
ernmental and traditional leadership capacities (purpose-
ful), which often depended on availability (opportunistic).
For the FGD, participants were selected through village
leaders and chosen for their leadership roles within, or as
respected members of the community.
The interviews were translated from Maasai into Eng-
lish and were analysed using the NVivo® ethnographic
software program. Primary analysis was done on the
notes of all 30 FGDs, and an initial coding scheme was
established. Key theme prevalence across all interviews
was assessed after summarizing and shortening
responses in an Excel spreadsheet. A selection of repre-
sentative FGDs (n = 13, 7 = women, 6 =men) were pur-
posefully selected for full audio transcription and
translation from Maasai or Swahili to English and deeper
qualitative analysis. Criteria for selection of FGDs for





Deworming team targets one sub-
village per day
Team sets up a deworming clinic in a
central point of the sub-village at
08:30 hours
All villagers invited to attend
Children between 12 and 59 months
given mebendazole (500mg) and
vitamin A (100,000 IU)
People over 59 months given an oral





Rabies team targets one sub-village
per day
Team sets up a vaccination clinic in
a central point of the sub-village at
08:30 hours
All villagers invited to bring their
dogs for vaccination
All dogs brought to clinic are
vaccinated with 1ml rabies vaccine,
have plastic collar placed around








Deworming activities carried out in
the same way as in Arm B
Rabies vaccination activities
carried out in the same way as in
Arm C
All villagers invited to attend
deworming clinic and invited to
bring their dogs for vaccination
Fig. 1 Flow chart describing the distribution of target villages and the activities that took place in each arm of the study
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transcription included clarity of discussion, articulation
of ideas and thematic saturation.
Objective 2a: household participation and dog ownership
To estimate i) the proportion of households that
attended the clinics, ii) the proportion of households
that kept dogs and iii) the mean number of dogs per
household, a post-intervention household questionnaire
survey (HQS) targeting randomly selected households
(maximum of 30 households per village) was carried out
within 1 week of each intervention. A target household
list comprising 50 randomly selected households was
used to allow for additional households to be selected if
households refused to participate or nobody was at
home. Because the interventions took a maximum of 6
days per village to complete, and to allow the implemen-
tation teams and the HQS data collection team to re-
main synchronised, the HQS data collection was also
designed to last for no more than 6 days. Consequently,
approximately five household per day were targeted,
with approximately the same number of households be-
ing targeted in each sub-village.
Because of budgetary and time limitations, HQS (and
coverage estimation) was carried out in only 16 of the 24
target villages. All eight villages in Arm A were targeted,
whilst four randomly selected villages in each of Arms B
and C were chosen prior to the onset of activities. No
households declined to participate, however if the family
were not at home the team moved onto the next house-
hold on the target household list. Chi squared tests were
used to determine whether household participation was
impacted by delivery strategy.
Objective 2b: dog vaccination coverage
A capture-mark-re-sight transect survey method was
used to estimate the proportion of dogs that were vacci-
nated [26]. In brief, a MDRV team member walked
through the sub-village on the day after the MDRV
clinic and counted the number of dogs, noting whether
each had been marked on the flank with the coloured
spray (vaccinated) or not (unvaccinated). These sub-
village totals were then used to estimate the proportion
of dogs for each village that had been vaccinated. This
estimation was performed in all eight Arm C villages
and six out of the eight Arm A target villages (rain-
storms made access difficult in two villages). The pro-
portions of dogs that were vaccinated or not in the
villages in each arm were compared using a generalized
linear mixed model (binomial family, with village as a
random effect).
Objective 2c: administration and delivery costs
Clinic administration and delivery (A&D) costs were col-
lected for all 24 villages, including variable costs (per
dose delivered, by dose type) and fixed costs (per clinic,
by clinic type). These costs allowed a cost per dose
(A&D) to be calculated. A detailed description of how
this data was collected and attributed to each Arm of
the study has been given in Additional file 1. In brief,
Method 1 calculates the total cost over all clinics (by
clinic type and Arm) divided by the total number of
doses delivered (by clinic type and Arm) and represents
the aggregate cost per dose for a given clinic category.
Method 2 calculates cost per dose on a per clinic basis,
and then averages over all clinics. Method 1 is useful as
an aggregate measure over all clinics but cannot be used
to test for statistical differences across clinic categories
because it is not calculated on a per clinic basis. Method
2 allows testing for statistical differences across clinic
types but represents a summary statistic for clinic-level
cost per dose measure rather than an aggregate measure.
The exchange rate for cost calculations was 2100 Tsh
per U.S. Dollar, approximately the exchange rate that
prevailed from mid-2015 through 2016 [36]. Mood’s me-
dian and Mann-Whitney Ranksum non-parametric tests
were used to test for differences in cost per dose be-
tween Arms A and B, and Arms A and C.
Objective 2d: travel time to attend clinics
To understand which mode of transport was most com-
monly used, people attending the clinics were asked how
they had travelled to the clinic (foot, carried (e.g. in-
fants), bike, car, etc.). To estimate the mean time it took
to attend a combined or single event, the same people
were also asked how long it took in minutes to reach the
events. In addition, the mean amount of time people
spent at a clinic and, for the integrated delivery (Arm A)
the mean time spent travelling between the two clinics,
was measured. These estimates were then used to com-
pare the overall time spent attending single and inte-
grated events. A detailed description of this analysis is
given in Additional file 1.
Objective 3: reaching school-aged children and others
To count the number of participating primary school
age children (7–13 years) that were enrolled or not in
school, every person (or accompanying guardian if the
person was a child) treated in all 16 Arm A and B vil-
lages was asked whether they were enrolled in primary
school and, if so, which primary school. Every partici-
pant was also asked their age, which allowed the range
of ages treated to be determined.
To investigate the proportion of enrolled school aged
children who received treatment in the MDA events of
this study, the number of children registered at the pri-
mary schools in the target villages was obtained from
the Ngorongoro District NTD Coordinator. To estimate
the percentage of enrolled school aged children in each
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school that received deworming treatment, the number
of children enrolled at each school that received treat-
ment was compared to the total number of enrolled chil-
dren. For reasons unspecified by the NTD Coordinator,
registration data was only available for 10 out of the 14
primary schools that participants attended,
All analyses were performed using R [37], except
the cost analysis which was performed using Stata®
version 14.2. All confidence intervals presented are at
the 95% level.
Results
Objective 1: community perceptions and knowledge
Analysis of the individual interviews and FGD revealed
opinions regarding integration of human / animal health
interventions. Opinions of combined human-animal
health programs were overwhelmingly positive across all
interview platforms. In a yes / no question, 98% of indi-
vidual interview respondents (n = 59) affirmed the com-
bined program was a “good idea” and 88% thought
integrating interventions would increase participation.
Furthermore, there were positive responses to combin-
ing health programs across the FGD with 85% conclud-
ing that they resulted in people getting “two for one”
health treatments, saved time, effort, and reduced par-
ticipant costs. However, in the individual interviews, 14%
explicitly expressed a negative opinion regarding com-
bined human – animal health interventions, with key
negative sentiments being that the strategy could be “un-
hygienic” or “difficult”. The reasons given most fre-
quently for not participating in health interventions
were walking distance (74%), time (61%) and costs asso-
ciated with attending (17%). In order to gauge which
intervention was more highly valued the respondents
were asked if they had to choose one intervention, either
to have their dogs vaccinated against rabies or their chil-
dren dewormed, which would they choose? In response,
60% chose to treat their children.
Quotes from respondents when asked to comment on
the combined program:
“To me there are no weaknesses only strengths because
from the time when rabies vaccination (program)
started we haven’t seen rabid dogs; and also it will
help to reduce these problems of worms which have
been another problem.”
“I see this is good because it reduces cost, we are
getting two services at once, and both people and dogs
will be treated in the same day.”
“Mostly people are willing to participate because of the
awareness they have about rabid dogs and how they
are dangerous to people; so it’s easy for them to
participate willingly at any time when other services
are delivered.”
Objective 2a: household participation and dog ownership
Full details of all target villages (including village and
sub-village names) and the number of dogs vaccinated
and / or people that received deworming treatment in
each are given in Additional file 2. A summary of the
number of people that received deworming treatment
and dogs that were vaccinated in each arm follows:
In Arm A eight villages were targeted to receive inte-
grated delivery of MDA and MDRV. In these villages the
number of people of all ages that received deworming
treatment ranged from 77 to 714 per village and the
number of dogs that were vaccinated ranged from 22 to
164 per village. The number of people (within specified
age ranges) that were dewormed, and the number of
dogs vaccinated in each village and sub-village in Arm A
is given in Additional file 3.
In Arm B eight villages were targeted to receive MDA
only. In these villages the number of people of all ages
that received deworming treatment ranged from 104 to
1014 per village. The number of people (within specified
age ranges) that were dewormed in each village and sub-
village in Arm B is given in Additional file 4.
In Arm C eight villages were targeted to receive
MDRV only. In these villages the number of dogs that
were vaccinated ranged from 29 to 141 per village. The
number of dogs vaccinated in each village and sub-
village in Arm A is given in Additional file 5.
In the villages in which the HQS survey was carried
out, up to 30 households per village participated in the
HQS. The median percentage of households per village
that participated in the MDA clinics in Arm A was
91.5% (range: 22–100%) and in Arm B was 82.5% (range:
69–94%). The median percentage of households per vil-
lage that participated in the MDRV clinics in Arm A
was 86.5% (range: 20–100%) and in Arm C was 90%
(range: 75–100%). The number of households that
responded that they did or did not participate in the
MDA clinic are shown for each village and sub-village in
Additional file 6. The number of households that
responded that they did or did not participate in the
MDRV clinic are shown for each village and sub-village
in Additional file 7. In addition, the median proportion
of households in each village and in each Arm that par-
ticipated in the respective clinics are shown.
When the responses from all of the households that
participated in the HQS were combined for each arm of
the study, 210 out of 257 (81.7%, CI: 76.5–86.0%) Arm
A households and 91 out of 115 (79.1% (CI: 70.8–85.6%)
Arm B households stated that they participated in the
MDA clinics (χ2 = 0.2, p = 0.66), and 156 out of 194
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(80.4%, CI: 74.3–85.4%) Arm A dog owning households
and 75 out of 85 (88.2%, CI: 79.7–93.5%) Arm C dog
owning households participated in the MDRV clinics
(χ2 = 2.0, p = 0.16). In Arm A, out of 194 dog owning
households that were questioned, 150 (77.3%, CI: 70.9–
82.6%) attended both the deworming and rabies clinics,
11 (6.3%, CI: 3.2–9.9%) attended deworming only, 6
(2.8%, CI: 1.4–6.6%) attended rabies only, whilst 27
(13.9% (CI: 9.7–19.5%) attended neither.
Of the 260 households that were asked about dog
ownership, 202 (78% (CI:72–82.3%)) owned one or more
dogs, and the mean number of dogs per household was
1.9 (CI: 1.7–2.1).
Objective 2b: dog vaccination coverage
The number of dogs that were counted as being marked
and unmarked in each village is given in Additional file
8. The mean proportion of dogs in Arm A and C that
were vaccinated was 63.8 and 67.3% (O.R. = 1.2, (95%
C.I = 0.7–2.1), z = 0.74, p = 0.45), respectively.
Objective 2c: administration and delivery costs
Clinic administration and delivery (A&D) costs col-
lected for all 24 villages, including variable costs (per
dose delivered, by dose type) and fixed costs (per
clinic, by clinic type), are given in Table 1, whilst
Table 2 provides a summary of the results of the A&D
cost analyses. Cost per dose was lower under inte-
grated delivery based on both Method 1 and 2 calcula-
tions. Using calculation Method 1 cost per dose for
deworming averaged $0.24 and $0.36 for Arm A and
B, respectively, a 33% reduction in cost per dose. Cost
per rabies vaccination averaged $4.36 and $5.18 in
Arm A and C, respectively, a 16% reduction in cost
per dose. Using Method 2, the average per-clinic
deworming cost per dose was $0.32 for Arm A and
$0.47 for Arm B, a 32% reduction in cost per dose (t =
− 2.5, df = 51, p = 0.017; a two-sample Mood’s median
test provides p = 0.004, and a Mann-Whitney Ranksum
test provides p = 0.0075). The average per clinic rabies
vaccination cost per dose was $5.40 for Arm A and
$6.06 for Arm C, an 11% reduction in cost per dose
(t = − 1.0, df = 56, p = 0.31; a two-sample Mood’s me-
dian test provides p = 0.43, and a Mann-Whitney
Ranksum test provides p = 0.245). Thus, the cost per
deworming dose was lower in Arm A under integrated
delivery, and statistically significantly so at conven-
tional levels based on Method 2, which calculates cost
per dose on a per-clinic basis and allows statistical
testing. Rabies delivery cost was also lower in Arm A,
although not statistically significantly so. Rabies deliv-
ery costs tended to be higher in total and per dose
than deworming, largely because the number of people
required for delivery was higher (per diem costs) and
prevailing wages for their expertise (embodied in
Labour costs).
Objective 2d: travel time to attend clinics
Across all arms of the study villagers travelled a mean of
22 min to and from the clinics (11 min each way, range
1 to 90 min), almost exclusively on foot, with infants be-
ing carried. Time spent at the clinic to register and re-
ceive treatment or dog vaccination was approximately
10 min. In Arm A, the walking time between the
deworming clinic and the rabies clinic was approxi-
mately 1 minute. Therefore, the time taken to attend a
non-integrated event (Arm B or C, or Arm A if not
bringing dogs) was approximately 32 min per person.
The time required for a single person with a dog to at-
tend an integrated event and receive the deworming and
dog vaccination (Arm A) was 43 min including travel. It
thus took 33% less time for a single person and a dog to
attend a combined event (e.g. Arm A) than to attend
two separate events (Arms B and C).
Objective 3: reaching school children and others
The proportion of children treated by this study in each
of the ten primary schools investigated is given in
Table 3. The mean and median percentage reached by
this study was 73.6 and 76%, respectively. The propor-
tion of primary school aged children in Arm A and B
villages combined that received treatment and stated
that they were not enrolled in school was 37%.
Figure 2 shows the age distribution of participants
who received deworming treatment and the age range of
those eligible to receive treatment through the NSDP.
Of people attending the deworming events 21% were
primary school age children (blue bars in Fig. 2). Of
these, 37% were not enrolled in school. Consequently,
86% of people who came for treatment were not primary
school age or were primary school age children not en-
rolled in school.
Table 1 Fixed and variable costs, by Arm and clinic type
Arm Arm A Arm B Arm C
Clinic MDA MDRV Both MDA MDRV
Fixed Costs 3640 8000 11,640 3900 8584
Variable Costs 169 484 653 115 434
Total costs 3808 8484 12,292 4015 9018
“Fixed costs” include i) event-level fixed costs not attributable to clinics, which
were allocated equally across all events, and ii) event-level fixed costs
attributable to either clinic type (MDA or MDRV), which were attributed equally
across all rabies or deworming events, respectively. Because there were two
clinics for each Arm A event, the event-level fixed costs not attributable to
clinics were allocated equally across both clinics in Arm A and were therefore
half that allocated to Arm B or C. Variable costs per clinic were dose-specific
costs multiplied by the number of doses delivered. Costs in 2016 US dollars
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Discussion
In this proof-of-concept study we generated several find-
ings that will be of value in informing the design of inte-
grated delivery interventions to improve human and
animal health in hard-to-reach communities. First, we
demonstrated that the concept of integrating a MDA fo-
cused on human health with one focused on animal
health can be feasible and practical. Second, a high pro-
portion of households targeted by the HQS stated that
they had participated in the integrated Arm A events,
and these proportions were similar to those in Arms B
and C where interventions were not integrated. Whilst
these figures only represent household participation and
not the number of people in each household that
attended, these findings, together with the broad com-
munity support and the similar rabies vaccination cover-
ages, suggest that coverage might not be reduced when
interventions are delivered as part of an integrated deliv-
ery strategy. Third, we demonstrated that integrated de-
livery resulted in a lower cost per dose delivered than if
each intervention had been delivered independently.
Fourth, because many school-aged children came for
treatment who were not enrolled at school, we hypothe-
sise that the strategy employed in this study (in which
delivery was located outside of the primary school prem-
ises and offered to the whole community) could, in
hard-to-reach areas where school enrolment might be
relatively low, reach more school-aged children than
would be reached through a solely school-based delivery
strategy. Fifth, integrated interventions also catalysed ef-
fective collaboration between human and animal health
workers with establishment of operational inter-sectoral
field teams. While this study was carried out in remote
areas of Tanzania and the benefits found regarding inte-
grated delivery platforms cannot be generalised to every
setting, the insights gained could be broadly applicable
to other populations in sub-Saharan Africa that are
hard-to-reach and / or underserved by health services.
A limitation of the study was that it was not powered
as a full randomized controlled trial. Despite this, steps
were taken where possible to randomize selection pro-
cesses and as such, and despite the small sample size, in-
ferences from the data were drawn. A second limitation
was the difficulty obtaining accurate village level human
population census data required for the denominator of
MDA deworming coverage calculations. As village level
census data were not available and we did not have
funding to carry out a village-wide census in all target
villages, we expected to estimate the human population
from the number of households per village. However,
due to sub-village divisions and mergers that have oc-
curred in recent years, village executive officers were un-
able to quantify with confidence the number of
households included within their village boundaries. Be-
cause of this we used the HQS, performed in 16 of the
24 villages, to calculate the proportion of households in
each village and Arm that participated in the interven-
tions. Although we were unable to calculate MDA
coverage estimates, the high level of household partici-
pation suggests that people were not discouraged from
attending a human health event when it was integrated
Table 2 The results of the administration and delivery cost analyses
Method Cost per dose Cost per vaccination Test
Arm A Arm B Arm A Arm C
Method 1 $0.24 $0.36 – – –
Method 1 – – $4.55 $5.40 –
Method 2 $0.32 $0.47 – – t = −2.5, df = 51, p = 0.017
Method 2 – – $5.65 $6.32 t = −1, df = 56, p = 0.32
The cost per deworming dose and per rabies vaccination for each Arm of the study as calculated by the two different calculation methods is given. Method 1 has
calculated the average of a ratio, whilst Method 2 has calculated the ratio of averages (or totals). Method 1 is useful as an aggregate measure over all clinics, but
cannot be used to test for statistical differences across clinic categories because it is not calculated on a per clinic basis. Method 2 allows testing for statistical
differences across clinic types, but represents a summary statistic for clinic-level cost per dose measure rather than an aggregate measure. The result of the
statistical analysis of Method 2 is given
Table 3 The target, the number and the proportion of enrolled
primary school children reached by the study’s MDA
deworming events in ten primary schools
School Target Treated Prop
Enguserosambu 333 329 0.99
Kritalo 511 225 0.44
Maaloni 324 208 0.64
Magaiduru 407 239 0.59
Njoroi 261 189 0.72
Oldonyowas 347 311 0.90
Orkuyeni 84 66 0.79
Ololosokwani 549 433 0.79
Orkiu Juu 379 224 0.59
Loliondo 1302 1198 0.92
The deworming treatment coverage of enrolled primary school children
achieved by the study in ten comparison schools. TARGET = the number of
school children enrolled in each school; TREATED = the number of school
children that received deworming treatment in the study; PROP = the
proportion of school children in each school that received treatment
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with one providing treatment for animals. This conclu-
sion is supported by the findings from the Chad Study
[32] in which a higher number of people were vaccinated
when delivery was integrated with livestock vaccination.
In a further comparison with the Chad study, strong
support was expressed across the interview platforms for
integrated delivery approaches suggesting that One
Health approaches are viable and, potentially, cost-
effective options for delivering health interventions to
remote communities. Support for integrated interven-
tions was articulated primarily in terms of time and cost
savings and the popularity of receiving multiple health
benefits at once. This focus on time saved was borne out
in Arm A in which a single person with a dog saved over
a third of their time compared to respondents attending
separate events. Given that over three quarters of house-
holds in the study kept dogs, with a mean of two dogs
per household, the delivery of integrated MDA and
MDRV interventions has the potential to benefit a large
proportion of households. However, the concerns of a
small proportion (14%) of informant interviews in de-
scribing animal and human health interventions as ‘un-
hygienic’ and ‘difficult’ should be noted and might need
to be addressed in designing future programs.
One concern regarding integrated One Health inter-
ventions is that one intervention might compromise the
outcomes for the other (e.g. logistical constraints of try-
ing to bring both young children and dogs to receive
treatment) and further understanding of potential trade-
offs and the nuances of preferences and attitudes would
be of value. Indeed, in response to the survey question
that asked: ‘If you had to choose one, which would you
choose: to have your dogs vaccinated against rabies or
your children wormed?’, 60% of respondents chose to
treat their children. It is not clear whether this reflects a
perception that it is better to been seen to say that you
would treat children rather than dogs (even if health
outcomes of both interventions benefit children) or a
more deliberate choice to protect children against the
ongoing but less severe effects of worms rather than the
more unlikely but lethal outcomes of rabies infection.
Although not significant, the coverage of dogs vacci-
nated was lower in the integrated arm and a larger study
might reveal there to be an impact. However, such im-
pacts could potentially be addressed through judicious
timing of events. For example, although for research
purposes this study was carried out in school term time,
it is the authors’ experience that it is often children who
Fig. 2 A bar chart showing the number of people of different ages that attended the community-wide deworming events in the study. Blue
colour indicates the age range (7–13 years) of primary school aged children in the United Republic of Tanzania that are targeted by the national
schools deworming programme (NSDP), whilst the orange colour represents the ages of people treated by the study that would have not been
reached by a primary school-based program
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are responsible for bringing dogs to central-point clinics
for vaccinations and scheduling integrated events during
school holidays might make it easier for families to bring
both children and dogs to the events, thus improving
vaccination coverage.
Another key finding was that the cost per dose deliv-
ered was lower under integrated strategies, with delivery
of deworming and rabies vaccination reduced, respect-
ively, by $0.12 (33%) and $0.82 (16%) per dose in com-
parison with single intervention strategies, and,
especially for rabies vaccination, these savings appear
not to be at the expense of participation in the disease
control program. The reduced costs were primarily due
to shared transportation costs in Arm A compared to
Arms B and C where deworming and rabies teams trav-
elled separately to their respective events. Further, being
able to advertise for deworming and rabies vaccination
events within the same announcements resulted in fur-
ther savings in Arm A. Similar cost savings, resulting
from shared information campaigns and vehicles, were
reported in the Chad Study [32]. Thus, the economies of
scope achieved by combining clinics in joint events
manifest as cost savings that can offset some reduction
in participation in terms of cost-effectiveness.
The mean percentage of enrolled school children
treated by this study (74%) was lower than the national
average (90%) reported by the NSDP [17], but was
broadly similar to an estimate of the coverage achieved
within the remote study region (78%) (calculated from
data obtained from the Ngorongoro District NTD Co-
ordinator). This suggests that a change of location
(i.e. close to, rather than within, a primary school)
might not result in a lower coverage of registered pri-
mary school children.
The study also suggested that non-enrolment in school
was considerably higher than the national average (20%
in 2014 [38]) with over a third of primary school aged
children that received treatment stating that they were
not enrolled in school. Because children who did not
come for treatment could not be included in the calcula-
tion (whether enrolled or non-enrolled), we cannot con-
sider these results indicative of the precise level of non-
enrolment. Furthermore, this level of non-enrolment will
not be generalizable across Tanzania with specific con-
straints likely to apply to children in these pastoral com-
munities [18]. Although non-enrolled children can be
invited to attend deworming events hosted within
schools [39], the level of non-enrolment recorded does
suggest that, in hard-to-reach areas, a purely school-
based delivery could miss a large fraction of school-aged
children, perhaps from households most vulnerable to
the health concerns being targeted.
Importantly, not being enrolled at school was not a
barrier to children attending the clinics, with many non-
enrolled school age children receiving deworming treat-
ment even when the clinics were located just outside of
the local primary school and where non-enrolled children
might be expected to be wary about presenting themselves
(primary school enrolment between the ages of 7 and 13
is compulsory in Tanzania). Moreover, because all age
groups were invited, many other community members
attended the events. Indeed, the enthusiasm with which
villagers attended the community-wide deworming events,
and the tone of the responses from the interview plat-
forms, indicated that the strategy was broadly welcomed
and that individuals from the community might be effect-
ively reached through extramural programs.
How important is it to reach a broader section of the
community? The principle objective of school-based
deworming programs is to alleviate morbidity and im-
prove educational and economic outcomes for children
[40]. However, treating primary school age children
alone will not bring worm burdens sufficiently close to
the breakpoint under which transmission is eliminated
[19]. Furthermore, any child missed will remain vulner-
able to infection and morbidity. Given our findings, this
will be a particular concern in areas such as the Ngoro-
ngoro District where school enrolment appears low.
Moreover, if local elimination of STH is the goal then, in
addition to improvements in hygiene, it has been sug-
gested that community-wide treatment of adults as well
as children (enrolled in school or not, and of all ages)
will likely be required at high levels of coverage (80–
90%) over multi-year programs [19]. Irrespective of the
scale of the deworming objectives (to reduce morbidity
of children only or the cessation of STH transmission)
there are likely to be substantial benefits from reaching
more children and a broader section of the population.
And, given the household participation rates and the en-
thusiastic attitudes recorded in this study, integrated de-
livery platforms could play a role in achieving the
required levels. However, a larger study is required to
fully evaluate the approach tested in this study.
Beyond the added value that may accrue from com-
plementarities and cost-savings, a noticeable, although
unmeasured, finding was the inter-sectoral (veterinary
/ medical) collaboration that developed as a result of
the integrated delivery intervention. With teams from
different Ministries working together in the field for
the first time to achieve common goals, it was appar-
ent that strong collaborative relationships were devel-
oping. The benefits that may accrue from this kind of
partnership in disease control needs investigating. The
study also supports the premise that the community
trust established through the delivery of a health
intervention with appreciated beneficial outcomes, in
this case the reduction in human rabies through dog
vaccination, might facilitate integration of a second
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intervention, here STH treatment. This may be a crit-
ical component when the goal is to achieve broad
community coverage for program success (e.g. vaccin-
ation, drug treatment). With donor and recipient fa-
tigue a growing concern and questions arising about
the cost-effectiveness and sustainability of large-scale
disease-specific interventions, this study provides opti-
mism that integrated approaches, including One
Health strategies that target both human and animal
populations, may provide feasible and cost-effective
options for delivering health interventions, particularly
in hard-to-reach communities.
Conclusions
This study demonstrated that integrated health delivery
platforms can be feasible, popular, cost saving and time
saving. Further, integrating human and animal health in-
terventions does not appear to constrain the reach of
dog rabies vaccination. The study also demonstrated that
children that were not enrolled in school attended the
extra-mural intervention. Such an approach could have
merit in remote areas where school enrolment might be
low. These results indicate the utility of integrated One
Health delivery platforms and suggest an important role
in the global campaign to reduce the burden of NTDs,
especially in hard-to-reach communities.
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